This is a double-blind clinical study of the efficacy of two corticosteroids in asthma using prednisone (P) and deflazacort (D). Patients receive an initial dose of prednisone - 40 mg daily for two weeks and then are randomized to D or P. Effective doses are compared by effects on symptoms and lung function during taper.
|Effective start/end date||1/10/89 → 30/09/91|
- National Center for Research Resources
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.